This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.
2019-nCoV Antigen test is intended for the direct and qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in anterior nasal swabs from individuals at home or for screening of individuals without symptoms or other reasons to suspect COVID-19 infection.
Easy test for SARS-CoV-2 infection whether you're symptomatic or asymptomatic.
2019-nCoV Antigen test is intended for the direct and qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in saliva from individuals at home or for screening of individuals without symptoms or other reasons to suspect COVID-19 infection.
Easy test for SARS-CoV-2 infection whether you're symptomatic or asymptomatic.
The kit is co-developed by Singapore Agency for Science, Technology and Research (A*STAR) Experimental Drug Development Centre, Bioinformatics Institute, The Diagnostics Development (DxD) Hub and Tan Tock Seng Hospital. The kit has received Singapore Health Science Authority (HSA) approval (MDPA2020-01) and has been deployed in Singapore public and private hospital labs. qPCR testing for specific RNA in nasopharyngeal swab samples. The analytical Limit of Detection (LOD) at 25 copies/reaction. No cross-reactivity with SARS-CoV, Influenza A H1N1, Influenza A H3N2, Influenza B and MERS-CoV. No false negative has been reported to-date
The kit is manufactured in Singapore
6 Diagnostic Kits Suppliers
Short on time? Let Diagnostic Kits sellers contact you.
